BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16725133)

  • 1. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients.
    Salm P; Warnholtz C; Boyd J; Arabshahi L; Marbach P; Taylor PJ
    Clin Biochem; 2006 Jul; 39(7):732-8. PubMed ID: 16725133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
    Khoschsorur G; Fruehwirth F; Zelzer S; Stettin M; Halwachs-Baumann G
    Clin Chim Acta; 2007 May; 380(1-2):217-21. PubMed ID: 17320846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation.
    Baldelli S; Crippa A; Gabrieli R; Fiocchi R; Perico N; Merlini S; Ottomano C; Cattaneo D
    Clin Biochem; 2006 Dec; 39(12):1152-9. PubMed ID: 17054930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
    Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
    Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
    Coentrão L; Carvalho C; Sampaio S; Oliveira JG; Pestana MI
    Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients.
    Morris RG; Salm P; Taylor PJ; Wicks FA; Theodossi A
    Ther Drug Monit; 2006 Apr; 28(2):164-8. PubMed ID: 16628125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.
    Bouzas L; Tutor JC
    Clin Biochem; 2007 Jan; 40(1-2):132-6. PubMed ID: 17011541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12-hour area under the curve cyclosporine concentrations determined by a validated liquid chromatography-mass spectrometry procedure compared with fluorescence polarization immunoassay reveals sirolimus effect on cyclosporine pharmacokinetics.
    Napoli KL
    Ther Drug Monit; 2006 Dec; 28(6):726-36. PubMed ID: 17164687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method.
    Bouzas L; Hermida J; Tutor JC
    Ups J Med Sci; 2009; 114(1):55-61. PubMed ID: 19242874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between a liquid chromatography-tandem mass spectrometry assay and a fluorescent polarization immunoassay to measure whole blood everolimus concentration in heart and renal transplantations.
    Dailly E; Deslandes G; Hourmant M; Petit T; Renaud C; Treilhaud M; Jolliet P
    J Clin Lab Anal; 2008; 22(4):282-5. PubMed ID: 18623123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of sirolimus and everolimus by immunoassay techniques: test specificity and cross-reactivity evaluation.
    Pieri M; Miraglia N; Gentile A; Polichetti G; Castiglia L; Federico S; Sabbatini M; Basile V; Tarantino G; Acampora A; Capone D
    Int J Immunopathol Pharmacol; 2008; 21(3):585-94. PubMed ID: 18831925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an immunoassay (Abbott-IMX Analyzer) allowing routine determination of sirolimus: comparison with LC-MS method.
    Bargnoux AS; Bonardet A; Chong G; Garrigue V; Deleuze S; Dupuy AM; Mourad G; Cristol JP
    Transplant Proc; 2006 Sep; 38(7):2352-3. PubMed ID: 16980087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of everolimus metabolite patterns in trough blood samples of kidney transplant patients.
    Strom T; Haschke M; Zhang YL; Bendrick-Peart J; Boyd J; Roberts M; Arabshahi L; Marbach P; Christians U
    Ther Drug Monit; 2007 Oct; 29(5):592-9. PubMed ID: 17898649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA; Dijkers EC; Uges DR
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.
    Wilson D; Johnston F; Holt D; Moreton M; Engelmayer J; Gaulier JM; Luthe H; Marquet P; Moscato D; Oellerich M; Mosso R; Streit F; Brunet M; Fillee C; Schmid R; Wallemacq P; Barnes G
    Clin Biochem; 2006 Apr; 39(4):378-86. PubMed ID: 16545357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine determinations in heart and liver transplant recipients: comparison of HPLC and FPIA methods on whole blood and plasma.
    Corda C; Escousse A; Santona L; Guédon F; Mounié J
    Therapie; 1991; 46(2):115-7. PubMed ID: 2053089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of QMS everolimus assay using Hitachi 917 Analyzer: comparison with liquid chromatography/mass spectrometry.
    Dasgupta A; Davis B; Chow L
    Ther Drug Monit; 2011 Apr; 33(2):149-54. PubMed ID: 21266941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new immunoassay to measure sirolimus blood concentrations compared to a tandem mass-spectrometric chromatographic analysis.
    Fillée C; Mourad M; Squifflet JP; Malaise J; Lerut J; Reding R; Borghgraef P; Vanbinst R; Wallemacq PE
    Transplant Proc; 2005; 37(6):2890-1. PubMed ID: 16182845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fluorescence polarization immunoassay and high-performance liquid chromatography methods for assay of teicoplanin: can correlation be improved?
    Davani S; Bérard M; Royer B; Kantelip JP; Muret P
    Pathol Biol (Paris); 2004 Dec; 52(10):584-8. PubMed ID: 15596307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.